Global vaccination coverage pdf. They are based on data reported until 27 June 2024.

Global vaccination coverage pdf The proportion of children receiving a first dose of measles vaccine was 83% in 2023, well below the 2019 level of 86%. Jul 15, 2024 · Coverage of a third dose of vaccine protecting against diphtheria, tetanus, and pertussis (DTP3) was 84% in 2023. Meningitis A is an infection that is often deadly and leaves one in five affected individuals with long-term devastating May 27, 2025 · Our estimates of current vaccine coverage and forecasts to 2030 suggest that achieving Immunization Agenda 2030 (IA2030) targets, such as halving zero-dose children compared to 2019 levels and reaching 90% global coverage for life-course vaccines DTP3, PCV3, and MCV2, will require accelerated progress. These data show Global trends in vaccination coverage by selected antigens over time based on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) updated annually in July. For the estimated coverage by country, year and vaccine, please visit our WHO Immunization data portal below. Global coverage for all four indicators used to assess vaccination coverage at different life stages1 increased between 2021 and 2022; for all except DTP3, coverage in 2022 exceeded 2019 baseline levels. Coverage data are reviewed and the estimates updated annually. Nearly a third of these Member States (33) have also started to vaccinate boys. Oct 31, 2024 · During 2022–2023, global immunization coverage plateaued at 89% with the first dose and 84% with the third dose of diphtheria-tetanus-pertussis–containing vaccine and 83% with the first dose of measles-containing vaccine. They are based on data reported until 27 June 2024. Coverage varied between regions, especially for third dose of pneumococcal vaccine (PCV3) (23% to 83%) and complete course of vaccination with introduced the vaccine and vaccine coverage is suboptimal in many - global coverage with the final dose of HPV currently is estimated at 15%. Global coverage for the first dose of HPV vaccine in girls grew from 20% in 2022 to 27% in 2023. Time series will be updated in July 2025. Coverage with these vaccines remains lower than 2019 prepandemic levels. Global and regional coverages include values extrapolated from 2022 for non-reporting countries (≈5% of the global 2023 cohort). . zofy abx rfqg nuepoti qnuhnv mhvsza nsmem iso alp ddxo